Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
Discover how AFABILITY founder Dr. Alison Gray is enabling the transition from animal-derived to non-animal-derived antibodies
The combined solution aims to enable researchers to reproducibly prepare samples of all types for mass spectrometry-based proteomics
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab
The GeneSys software now combines sample positioning and image capture on one screen, making it easier for scientists to set up and image gels and blots in fewer clicks
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
